Approximately 50% of patients with severe mitral regurgitation (MR) referred for surgery have prohibitive surgical risk. MitraClip (Abbott Vascular) is an alternative therapy option in these patients. The aim of this study is to evaluate mid-term outcome in patients who underwent MitraClip implantation.
Mid-Term Clinical Outcomes Following Percutaneous Mitral Valve Edge-to-Edge Repair / Demir, Ozan M; Ruffo, Martina Maria; Godino, Cosmo; Ancona, Marco; Ancona, Francesco; Stella, Stefano; Munafó, Andrea R; Sisinni, Antonio; Agricola, Eustachio; Colombo, Antonio; Chieffo, Alaide; Montorfano, Matteo. - In: THE JOURNAL OF INVASIVE CARDIOLOGY. - ISSN 1557-2501. - (2020).
Mid-Term Clinical Outcomes Following Percutaneous Mitral Valve Edge-to-Edge Repair
Agricola, Eustachio;Chieffo, Alaide;Montorfano, Matteo
2020-01-01
Abstract
Approximately 50% of patients with severe mitral regurgitation (MR) referred for surgery have prohibitive surgical risk. MitraClip (Abbott Vascular) is an alternative therapy option in these patients. The aim of this study is to evaluate mid-term outcome in patients who underwent MitraClip implantation.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
